Limited Recommendations and Evidence for Timing and Frequency of Anti-Mullerian Hormone Screening in Female Pediatric Cancer Survivors: A Systematic Review from the Pediatric and Adolescent Committee of the Oncofertility Consortium
Journal of Adolescent and Young Adult Oncology · 01.06.2025 · 14 (3) · 212-219
DOI: 10.1089/jayao.2024.0111 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Journal of Adolescent and Young Adult Oncology, erschienen am 01.06.2025. Verfasst von Seth J Rotz und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Hematology, Oncology, and Blood and Marrow Transplantation, Cleveland Clinic, Cleveland, Ohio, USA. Hauptthemen laut MEDLINE: Anti-Mullerian Hormone, Cancer Survivors, Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatric Hematology, Oncology, and Blood and Marrow Transplantation, Cleveland Clinic, Cleveland, Ohio, USA.
- Division of Pediatric Hematology, Department of Pediatrics, Oncology and Stem Cell Transplant, Riley Hospital for Children, Indiana University School of Medicine, Indianapolis, Indiana, USA.
- Department of Obstetrics and Gynecology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
- Department of Obstetrics and Gynecology, MedStar Washington Hospital Center, Washington, District of Columbia, USA.
- Pediatric and Adolescent Gynecology, National Institute of Child Health and Human Development, Bethesda, Maryland, USA.
- Pediatric and Adolescent Gynecology Program, Children's National Hospital, Washington, District of Columbia, USA.
ORCID-Profile: Seth J Rotz
Zitieren
APA
Rotz, S. J., Bjornard, K., Hampanda, K., Kumnick, A., Maher, J. C. Y., Yu, C., & Appiah, L. (2025). Limited Recommendations and Evidence for Timing and Frequency of Anti-Mullerian Hormone Screening in Female Pediatric Cancer Survivors: A Systematic Review from the Pediatric and Adolescent Committee of the Oncofertility Consortium. Journal of Adolescent and Young Adult Oncology, 14(3), 212-219. https://doi.org/10.1089/jayao.2024.0111
Vancouver
Rotz SJ, Bjornard K, Hampanda K, Kumnick A, Maher JCY, Yu C, et al. Limited Recommendations and Evidence for Timing and Frequency of Anti-Mullerian Hormone Screening in Female Pediatric Cancer Survivors: A Systematic Review from the Pediatric and Adolescent Committee of the Oncofertility Consortium. Journal of Adolescent and Young Adult Oncology. 2025;14(3):212-219. doi:10.1089/jayao.2024.0111
BibTeX
@article{Rotz2025,
author = {Rotz, Seth J and Bjornard, Kari and Hampanda, Karen and Kumnick, Allison and Maher, Jacqueline C Yano and Yu, Christine and Appiah, Leslie},
title = {Limited Recommendations and Evidence for Timing and Frequency of Anti-Mullerian Hormone Screening in Female Pediatric Cancer Survivors: A Systematic Review from the Pediatric and Adolescent Committee of the Oncofertility Consortium},
journal = {Journal of Adolescent and Young Adult Oncology},
year = {2025},
volume = {14},
number = {3},
pages = {212--219},
doi = {10.1089/jayao.2024.0111}
}
EUVIMED